277 related articles for article (PubMed ID: 21792729)
21. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease.
Nagayama H; Hamamoto M; Ueda M; Nagashima J; Katayama Y
J Neurol Neurosurg Psychiatry; 2005 Feb; 76(2):249-51. PubMed ID: 15654042
[TBL] [Abstract][Full Text] [Related]
22. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?
Treglia G; Cason E; Cortelli P; Gabellini A; Liguori R; Bagnato A; Giordano A; Fagioli G
J Neuroimaging; 2014; 24(2):149-54. PubMed ID: 23163913
[TBL] [Abstract][Full Text] [Related]
23. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease.
Taki J; Yoshita M; Yamada M; Tonami N
Ann Nucl Med; 2004 Sep; 18(6):453-61. PubMed ID: 15515743
[TBL] [Abstract][Full Text] [Related]
24. (123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies.
Orimo S; Yogo M; Nakamura T; Suzuki M; Watanabe H
Ageing Res Rev; 2016 Sep; 30():122-33. PubMed ID: 26835846
[TBL] [Abstract][Full Text] [Related]
25. Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET.
Ishibashi K; Saito Y; Murayama S; Kanemaru K; Oda K; Ishiwata K; Mizusawa H; Ishii K
Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):3-11. PubMed ID: 19626324
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic Value of the Early Heart-to-Mediastinum Count Ratio in Cardiac 123I-mIBG Imaging for Parkinson's Disease.
Frantellizzi V; Lavelli V; Ferrari C; Sardaro A; Farcomeni A; Pacilio M; Borrazzo C; Pani R; Rubini G; Vincentis G
Curr Radiopharm; 2021; 14(1):64-69. PubMed ID: 32720610
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity and specificity of cardiac metaiodobenzylguanidine scintigraphy in the early diagnosis of Parkinson's disease.
Brandl SJ; Braune S
Clin Auton Res; 2019 Dec; 29(6):567-574. PubMed ID: 29869732
[TBL] [Abstract][Full Text] [Related]
28. 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.
Nuvoli S; Spanu A; Piras MR; Nieddu A; Mulas A; Rocchitta G; Galleri G; Serra PA; Madeddu G
Medicine (Baltimore); 2017 May; 96(21):e6967. PubMed ID: 28538394
[TBL] [Abstract][Full Text] [Related]
29. [Early alteration of adrenergic cardiac function in parkinsonisms with Lewy bodies].
Jiménez-Hoyuela García JM; Campos Arillo V; Rebollo Aguirre AC; Gómez Doblas JJ; Gutiérrez Hurtado A
Rev Esp Med Nucl; 2005; 24(2):93-100. PubMed ID: 15745679
[TBL] [Abstract][Full Text] [Related]
30. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
[TBL] [Abstract][Full Text] [Related]
31. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
[TBL] [Abstract][Full Text] [Related]
32. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
[TBL] [Abstract][Full Text] [Related]
33. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
[TBL] [Abstract][Full Text] [Related]
34. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Orimo S
Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
[TBL] [Abstract][Full Text] [Related]
35. [[(123)I]-Ioflupane SPECT in combination with MIBG myocardial scintigraphy in Parkinson's disease: a case series study].
Yamada A; Murakami T; Kang Y; Iikuni Y; Morimatsu A; Shirata A; Ito H; Ugawa Y; Yamane K
Rinsho Shinkeigaku; 2016 Jun; 56(6):400-6. PubMed ID: 27212677
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of dementia with Lewy bodies: can
Sakamoto F; Shiraishi S; Tsuda N; Hashimoto M; Tomiguchi S; Ikeda M; Yamashita Y
Br J Radiol; 2017 Feb; 90(1070):20160156. PubMed ID: 27897064
[TBL] [Abstract][Full Text] [Related]
37.
Yang T; Wang L; Li Y; Cheng M; Jiao J; Wang Q; Guo H
J Neurol Sci; 2017 Feb; 373():48-51. PubMed ID: 28131225
[TBL] [Abstract][Full Text] [Related]
38. Autopsy Validation of the Diagnostic Accuracy of
Matsubara T; Kameyama M; Tanaka N; Sengoku R; Orita M; Furuta K; Iwata A; Arai T; Maruyama H; Saito Y; Murayama S
Neurology; 2022 Apr; 98(16):e1648-e1659. PubMed ID: 35256483
[TBL] [Abstract][Full Text] [Related]
39. Prospective study of relevance of
Alves Do Rego C; Namer IJ; Marcel C; Lefebvre F; Lagha-Boukbiza O; Renaud M; Tranchant C; Anheim M
J Neurol; 2018 Sep; 265(9):2033-2039. PubMed ID: 29956027
[TBL] [Abstract][Full Text] [Related]
40. Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson's Disease.
Asahi T; Kashiwazaki D; Yoneyama T; Noguchi K; Kuroda S
Neurol Med Chir (Tokyo); 2016; 56(3):125-31. PubMed ID: 26794041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
